Australia's most trusted
source of pharma news
Posted 1 December 2021 PM
Medicines Australia has announced the winners of a competitive tender process to be 'lead support' for its much anticipated independent review of Health Technology Assessment to better handle orphan drugs, precision medicine and new technologies.
Shawview Consulting, headed by former MA CEO Brendan Shaw and strategic planning and market research firm Biointelect, founded by Jennifer Herz, will commence work to help get the review underway.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.